Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety, and tolerability of oral OPC-34712 in combination with aripiprazole for acute schizophrenia; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-03